Results 231 to 240 of about 4,510,822 (391)

Sulfate‐Directed Silver Dendrites with Enhanced Stability for Ultrasensitive SERS‐Based Therapeutic Drug Monitoring

Advanced Science, EarlyView.
This study presents sulfate‐directed silver dendrites (s‐AgDs) as oxidation‐resistant SERS substrates with long‐term stability, reproducibility, and sub‐picomolar sensitivity. Sulfate ions guide anisotropic growth and protect the surface, enabling improved performance over 7 months under ambient conditions.
Aradhana Dwivedi, Jan Dellith, Anna Makarova, Samir F. El‐Mashtoly, Juergen Popp, Vladimir Sivakov, Dana Cialla‐May   +6 more
wiley   +1 more source

The intersection of prescription drugs and medical devices: the evaluation and funding challenges of two categories of emerging health technologies. [PDF]

Int J Technol Assess Health Care
Rodrigues C, Fu R, Ghose T, Yurga E, Nauenberg E.   +4 more
europepmc   +1 more source

Stemming the Escalating Cost of Prescription Drugs: A Position Paper of the American College of Physicians.

Annals of Internal Medicine, 2016
H. Daniel
semanticscholar   +1 more source

Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain

Advanced Science, EarlyView.
ABSTRACT The blood‐brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease‐related DNA from the brain unreliable. Here, we demonstrate that microbubble‐enhanced focused ultrasound (MB‐FUS) mediated BBB opening, supported by large‐data models predict sonication regimens for safe and ...
Hohyun Lee, Victor Menezes, Shiqin Zeng, Chulyong Kim, Cynthia M. Baseman, Jae Hyun Kim, Samhita Padmanabhan, Pranav Premdas, Naima Djeddar, Anton Bryksin, Nikhil Pandey, Pavlos Anastasiadis, Anthony J. Kim, Tobey J. MacDonald, Chetan Bettegowda, Graeme F. Woodworth, Felix J. Herrmann, Costas Arvanitis   +17 more
wiley   +1 more source

Characteristics of High-Cost Beneficiaries of Prescription Drugs in Kazakhstan: A Cross-Sectional Study of Outpatient Data from 2022. [PDF]

Clinicoecon Outcomes Res
Nazarbayev A, Nurbakyt A, Omirbayeva B, Akhmetzhan A, Kosherbayeva L.   +4 more
europepmc   +1 more source

Trends in the number of LEP prescriptions according to the NDB Open Data and the drug price of NET/EE and DRSP/EE (2014–2023).

Motoyuki Nakao (3918893), Kotaro Kuwaki (17429840), Keiko Yamauchi (455503), Kyoko Nomura (32284), Shinichi Tanihara (21743726)   +4 more
openalex   +1 more source

Consumer attitudes towards direct advertising of prescription drugs - a UK perspective [PDF]

, 2011
Fernando Lopes, John Egan, Joe Lynch
openalex  

Prescription pattern of drugs used for neuropathic pain and adherence to NeuPSIG guidelines in cancer

, 2020
Vishal Singh, Yashashri Shetty, Naveen Salins, Parmanand Jain   +3 more
openalex   +1 more source

The impact of diabetes on prescription drug costs: the population-based Turin study [PDF]

, 2008
Graziella Bruno, Ludmi la Karaghiosoff, Franco Merletti, Giuseppe Costa, Mónica María, Francesco Panero, Olivia Segre, P. Cavallo‐Perin, Roberto Gnavi   +8 more
openalex   +1 more source

Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emulation

Advanced Science, EarlyView.
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang, Min‐Yu Tsou, Pin‐Hung Li, Jo‐Ching Chen, Yen‐Liang Liu, Gideon Meyerowitz‐Katz, Tsung‐Hsun Tsai, Pen‐Hua Su   +7 more
wiley   +1 more source